InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Primeâ„¢ 80 cm Carotid Stent System for Use in TCAR procedures
Marvin Slosman, Chief Executive Officer of InspireMD, commented, “With more than 30,000 TCAR procedures performed in the U.S. each year, TCAR is a rapidly growing procedure that represents a ...